Trial studying safety and effects for HIV Seropositivity
Official title Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
ClinicalTrials.gov ID: NCT05723653
What this study is testing
- What it's testing
- This study is testing whether a flexible support program that uses friends and family can help people with HIV stay in care and reduce their virus levels.
- Who it's for
- You may be able to join if you are 18‑49 years old, have HIV, and want help staying in care.
- What's involved
- You will receive support from people in your social network, and you will have a few visits and check‑ins to track your care and health.
- Time commitment
- The study lasts several months and includes a few visits and check‑ins during that time.
- Time commitment: about 12 months
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 49. Healthy volunteers may be eligible.
You may be able to join if
- Aged 18-49 years old, inclusive
- Speak English
- Own a cell phone not shared with anyone else
- Have missed at least one HIV care scheduled visit or have not been virally suppressed in the past 24 months.
- Resides in Chicagoland, Illinois or Alabama
You likely can't join if
- Index agrees to engage the Support Confidant
- Age 18 years or older
- Speaks English
- Owns a cell phone not shared with others
- Romantic/Sexual partners of Index participant
- Relationship strain or abuse present in Index-Support Confidant relationship
The study team makes the final eligibility decision.
Where it is enrolling
- Birmingham, Alabama, United States
- Huntsville, Alabama, United States
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 49 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Birmingham, Alabama, United States; Huntsville, Alabama, United States; Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.